Physician profile
Kyle J Mangels
NPI 1174585640
$8,207.27
in general payments reported to CMS, 2019-2025
9 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,193 · 2020: $1,180 · 2021: $541 · 2022: $952 · 2023: $788 · 2024: $466 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,340.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,262.11 | 2021-2025 | Unid_pass, Catalyft Pl Expandable Interbody System, Mazor X System |
| Medtronic USA, INC. | $2,913.34 | 2019-2020 | |
| Stryker Corporation | $1,290.61 | 2019-2020 | |
| Alphatec Spine, INC | $390.85 | 2021-2022 | |
| Globus Medical, INC. | $151.42 | 2019 | |
| Cerapedics INC. | $98.99 | 2022 | |
| Pfizer INC. | $58.99 | 2025 | |
| Zimmer Biomet Holdings, INC. | $22.95 | 2021 | |
| Radius Health, INC. | $18.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Mangels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.